Table 2.

Amount of clonotypes in baseline, end-of-trial and specific T cell cultures.

Patient	Chain	N, clonotypes, baseline	N, clonotypes, end of trial	N, clonotypes in specific fraction cells	N, clonotypes in specific fraction > 1% frequency	Fraction of specific clonotypes in baseline sample	Fraction of specific clonotypes in end-of-trial sample	Fraction of specific clonotypes in the specific T cell sample
1	α	3601	5113	110	23	0%	0,022%	89,011%
	β	11837	20857	198	22	0%	0,039%	86,089%
2	α	4868	8935	25	5	0%	0%	99,028%
	β	24124	35587	27	5	0%	0,001%	99,492%
7	α	14159	3420	3	2	0%	0,018%	99,877%
	β	52996	10896	206	1	0%	0%	99,477%
9	α	4831	962	279	19	0%	0%	82,825%
	β	11941	3113	958	13	0,016%	0,046%	69,027%